RAS: Striking at the Core of the Oncogenic Circuitry

Gimple, Ryan C., Wang, Xiuxing·2019·Frontiers in Oncology
DOI 10.3389/fonc.2019.00965

Cited by (175)

Items 101–175 of 175

  1. Changes in cell morphology and function induced by the NRAS Q61R mutation in lymphatic endothelial cells
    Shiho Yasue, Michio Ozeki, Akifumi Nozawa, Saori Endo, Hidenori Ohnishi · 2024 · PLoS ONE
  2. Ras promotes germline stem cell division in Drosophila ovaries
    Qi Zhang, Yanfang Wang, Zhenan Bu, Yang Zhang, Qian Zhang, Le Li, Lizhong Yan, Yuejia Wang, Shaowei Zhao · 2024 · Stem Cell Reports
  3. vHTS and 3D-QSAR for the Identification of Novel Phyto-inhibitors of Farnesyltransferase: Validation of Ascorbic Acid inhibition of Farnesyltransferase in an Animal Model of Breast Cancer
    Damilohun Samuel Metibemu · 2021 · Drug Research
  4. Oncolytic viruses in immunotherapy
    Ilse Hernandez-Aguirre, Kevin A. Cassady · 2021 · Elsevier eBooks
  5. RAS: Circuitry and therapeutic targeting
    Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
  6. Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis
    Ramya Ephraim, Sarah Fraser, Jeannie Devereaux, Rhian G Stavely, Jack Feehan, Rajaraman D. Eri, Kulmira Nurgali, Vasso Apostolopoulos · 2023 · Cancers
  7. Integrins in cancer: insights into mechanisms and therapeutic potential
    Parth Agarwal, Rachana Raman, Prasoon Agarwal, Vijendra Prabhu, Praveen Kumar · 2026 · Cell Communication and Signaling
  8. Are connexin hemichannels playing any role in cancer?
    Andrés Tittarelli, Kevin Calderón, María de Los Ángeles Esveile, Antonia B Abusleme, Mariana P Arbat, Mauricio Antonio Retamal · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  9. Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors
    Zhen Yang, Wei Cui, Ruoying Yu, Xinhua Dong, Jian Zhao, Lu Dai, Qiuxiang Ou, Hua Bao, Xue Wu, Chuanxin Wu et al. · 2022 · Frontiers in Oncology
  10. Protein S-palmitoylation regulates different stages of meiosis in Schizosaccharomyces pombe
    Thanh Vy Pham, Wan‐Yi Hsiao, Yi-Ting Wang, Shu‐Dan Yeh, Shao-Win Wang · 2023 · Life Science Alliance
  11. Effect of Harvey Rat Sarcoma Virus Mutation in Oral Squamous Cell Carcinoma and Its Influence on Different Populations: A Systematic Review
    Mudiyayirakkani Muthusamy, Pratibha Ramani, Paramasivam Arumugam · 2023 · Cureus
  12. Effects of photobiomodulation by low power lasers on the in vitro proliferation and aggressiveness of breast cancer cells
    K S Canuto, Ísis Salviano Soares de Amorim, Juliana Alves Rodrigues, Adilson Fonseca Teixeira, André Luiz Mencalha, Adenilson de Souza da Fonseca · 2021 · Laser Physics
  13. The effect of parental age on the quantity and quality of offspring in Syngnathus typhle, a species with male pregnancy
    Freya A. Pappert, Daniel Kolbe, Arseny Dubin, Olivia Roth · 2024 · Evolutionary Applications
  14. Breast cancer genomic analyses reveal genes, mutations, and signaling networks
    Gowrang Kasaba Manjunath, Srihari Sharma, Disha Nashier, Shruthi Vasanthaiah, Spriha Jha, Saloni Bage, Tamoghna Mitra, Pankaj Goyal, Muniasamy Neerathilingam, Abhishek Kumar · 2024 · Functional & Integrative Genomics
  15. Genomic complexity and clinical significance of the RCCX locus
    Vladimir V. Shiryagin, Andrei A. Deviatkin, Oleg D. Fateev, Ekaterina Sergeevna Petriaikina, Viktor P. Bogdanov, Zoya Antysheva, Pavel Volchkov, Sergey Mikhailovich Yudin, Mary V. Woroncow, Veronika Igorevna Skvortsova · 2024 · PeerJ
  16. NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs
    Muhammed Iraqi, Priyanka Bolel, Rhitajit Sarkar, Baisali Bhattacharya, Muhammad Abu Ahmad, Avishay Edri, Laila C. Roisman, Moshe Elkabets, Walid Shalata, Nir Peled et al. · 2022 · International Journal of Molecular Sciences
  17. BRCA1 and NORE1A Form a Her2/Ras Regulated Tumor Suppressor Complex Modulating Senescence
    Nicholas C Nelson, Raphael Jigo, Geoffrey J. Clark · 2023 · Cancers
  18. Comparative transcriptional analysis identifies genes associated with the attenuation of Theileria parva infected cells after long-term in vitro culture
    Elisabeth M. D. L. van der Heijden, Lucas Lefèvre, Anton G. Gossner, Thomas Tzelos, Timothy Connelley, Musa A. Hassan · 2024 · Scientific Reports
  19. Recent advances in targeted degradation in the RAS pathway
    Zhiming Ge, Zisheng Fan, Wei He, Guizhen Zhou, Yidi Zhou, Mingyue Zheng, Sulin Zhang · 2025 · Future Medicinal Chemistry
  20. An Mb1-Cre-driven oncogenic Kras mutation results in a mouse model of T-acute lymphoblastic leukemia/lymphoma with short latency and high penetrance
    Jacob J. Junco, Taylor J Chen, Raushan Rashid, Maci Terrell, Vincent Ulysses Gant, Matthew Miller, Rachel E. Rau, H. Daniel Lacorazza, Karen R. Rabin · 2020 · Leukemia
  21. Interplay Between KRAS and LZTR1 Protein Turnover, Controlled by CUL3/LZTR1 E3 Ubiquitin Ligase, is Disrupted by KRAS Mutations
    Andreas Damianou, Zhu Liang, Frederik Heymann Lassen, George Vere, Svenja Hester, Philip D. Charles, Adán Pinto-Fernández, Alberto Santos-Delgado, Roman Fischer, Benedikt Mathias Kessler · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  22. From G12C To pan-RAS: The expanding therapeutic landscape of KRAS-mutant NSCLC
    Kübra Canaslan, Yasemin Başbınar, İlhan Öztop · 2026 · Critical Reviews in Oncology/Hematology
  23. Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights
    Karolina Mikołajczak, James Chmiel, Jerzy Leszek · 2026 · Cells
  24. Profiling Complex RAS-Effector Interactions Using NMR Spectroscopy
    Regina Strakhova, Matthew James Smith · 2024 · Methods in molecular biology
  25. Crossroads of cell fate: miR-34-mediated regulation of apoptosis and autophagy in glioblastoma
    Tareq Nayef AlRamadneh, Waleed K. Abdulsahib, Sajida Hussein Ismail, Rangaswamy Roopashree, Priya Priyadarshini Nayak, S. Usha Nandhini, Vimal Arora, Ashish Singh Chauhan, Oybek Ruziyev · 2025 · Discover Oncology
  26. Novel Small Molecules Capable of Blocking mtRAS-Signaling Pathway
    Namkyoung Kim, Injae Shin, Younghoon Kim, Eunhye Jeon, Ji‐Won Lee, Chaeyoung Lee, Yunju Nam, Sumin Lee, Eunhye Ju, Chan Kim et al. · 2021 · Frontiers in Oncology
  27. Cross-species analysis of differential transcript usage in humans and chickens with fatty liver disease
    Kaj Chokeshaiusaha, Thanida Sananmuang, Denis Puthier, Catherine Nguyen · 2023 · Veterinary World
  28. Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant models
    Peng, Shengbin, Zhang, Youyan, Lin, Xi, Si, Chong, Van Horn, Robert Daniel, Dempsey, Jack A., Goetz, Eva, Evans, Robert J., Farber, Andrew, Vandekopple, Matthew J. et al. · 2026 · Nature Communications
  29. KRAS Promoter Methylation Status and miR-18a-3p and miR-143 Expression in Patients With Wild-type KRAS Gene in Colorectal Cancer
    J A Herrera Pulido, Orlando Ricaurte Guerrero, Jinneth Acosta Forero, Pablo Moreno‐Acosta, Alfredo Ernesto Romero-Rojas, María Carolina Sanabria, Gustavo Hernández, Martha Lucía Serrano · 2022 · Cancer Diagnosis & Prognosis
  30. Molecular determinants of Ras-mTORC2 signaling
    Stephen F. Smith, A. F. M. Tariqul Islam, Shoxruxxon Alimukhamedov, Ethan T Weiss, Pascale G. Charest · 2024 · Journal of Biological Chemistry
  31. Comprehensive analysis of mutational features of colorectal cancer and multiple primary cancers including colorectal component: Data from the Cancer Genome Atlas
    Н. Н. Тимошкина, Dmitry Yu. Gvaldin, Moez Eid, Dema Alset, Nataliya A. Petrusenko, Inna Arnoldovna Novikova, Oleg Ivanovich Kit · 2024 · Human Gene
  32. Advancing KRAS drug discovery: A deep dive into biochemical, biophysical, and cellular assays for the identification and optimization of KRAS inhibitors
    Anthony N. Milin, John P. Giddens, Abby Marquez · 2024 · Elsevier eBooks
  33. Novel paradigms in KRAS targeting: Unveiling strategies to combat drug resistance
    Xiyuan Luo, Feihan Zhou, Yuemeng Tang, Xiaohong Liu, Ruilin Xiao, Minzhi Gu, Jialu Bai, Decheng Jiang, Gang Yang, Lei You et al. · 2025 · Chinese Medical Journal
  34. A Double Jeopardy: Loss of FMRP Results in DSB and Down-regulated DNA Repair.
    Arijita Chakraborty, Andre Grageda, Vladimir A. Kuznetsov, Wenyi Feng · 2022 · PubMed
  35. A MicroRNA-Based Method for High-Viremia Detection—A New Approach on a Romanian Lot of Chronically Infected Patients with Hepatitis B Virus
    Marina Manea, Dimitri Apostol, Ileana Constantinescu · 2023 · Diagnostics
  36. The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma
    Redir T Hassan, Bashar Al Hassawi, Maysoon Alkazzaz · 2024 · Cureus
  37. Quantitative Membrane Proteomics for Discovery of Actionable Drug Targets at the Surface of RAS-Driven Human Cancer Cells
    Xiaoying Ye · 2024 · Methods in molecular biology
  38. K-RAS Is…Complicated
    Geoffrey J. Clark · 2023 · Cancers
  39. A complex mechanism translating variation of a simple genetic architecture into alternative life-histories
    Jukka‐Pekka Verta, Jacqueline Emmanuel Moustakas-Verho, Iikki Donner, Morgane Frapin, Annukka Ruokolainen, Paul V. Debes, Jaakko Erkinaro, Craig Robert Primmer · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Loss of PRC2 Enforces a Mesenchymal Neural Crest Stem Cell Phenotype in NF1-Deficient Cancer Through Activation of Core Transcription Factors
    Xiyuan Zhang, Hannah E. Lou, Vishaka Gopalan, Zhihui Liu, Haiyan Lei, Catherine Paige Jones, Carly M. Sayers, Marielle E. Yohe, Prashant Chittiboina, Brigitte C. Widemann et al. · 2021 · SSRN Electronic Journal
  41. Multi-omics characterization of pancreatic neuroendocrine neoplasms
    Chi Fu Kevin Yang · 2021 · Summit (Simon Fraser University)
  42. Photodynamic therapy targeting nucleic acid G-quadruplexes
    Takeru Torii, Natsuki Kinoshita, Ryoto Urano, Daisuke Miyoshi, Keiko Kawauchi · 2022 · Journal of The Society of Japanese Women Scientists
  43. Navigating Uncharted Waters: Could Certain COVID-19 Vaccines Promote Malignancy?
    Raquel Valdes Angues, Yolanda Perea Bustos · 2022
  44. The role of dual-specificity phosphatase 6 (DUSP6) in metastasis and metabolism of pancreatic cancer cells
    Mariana T. Ruckert · 2022
  45. Voies en aval des récepteurs à activité tyrosine kinase
    Jacques Robert · 2023 · Elsevier eBooks
  46. Changes in cell morphology and function induced by NRAS Q61R mutation in lymphatic endothelial cells
    Shiho Yasue, Michio Ozeki, Akifumi Nozawa, Saori Endo, Hidenori Ohnishi · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Navigating Uncharted Waters: Could COVID-19 and/or Certain COVID-19 Vaccines Promote Malignancy?
    Raquel Valdes Angues, Yolanda Perea Bustos · 2023
  48. Navigating Uncharted Waters: Could COVID-19 and/or Certain COVID-19 Vaccines Promote Malignancy?
    Raquel Valdes Angues, Yolanda Perea Bustos · 2023
  49. Therapeutic Targeting of KRAS Oncogene in Pancreatic Ductal Adenocarcinoma (PDAC)
    Jeffrey J. Song · 2024 · Journal of Student Research
  50. The amino acid transporter SLC7A5 drives progression of PI3K-mutant intestinal cancer models and enhances response to MAPK-targeted therapy
    Owen James Sansom, Lucas B. Zeiger, Catriona A. Ford, Laura M. Millett, Valérie S. Méniel, Arafath Kaja Najumudeen, Kathryn A.F. Pennel, Natalie C. Fisher, Kathryn L. Gilroy, Nathalie Sphyris et al. · 2024 · Research Square
  51. Uev1A counteracts oncogenic Ras stimuli in both polyploid and diploid cells
    Qi Zhang, Yunfeng Wang, Xueli Fu, Ziguang Wang, Yang Zhang, Lizhong Yan, Yuejia Wang, Muhan Yang, Dan Song, Ruixing Zhang et al. · 2026 · eLife
  52. Prognostic biomarker RIMS1 and its association with immune infiltration in glioblastoma
    Erxing Tao, Qimin Song, Jialin Tang, Wenqiang Xin, Zhipeng Xiao, Zhixin Liu, Guangbin Xie · 2025 · Scientific Reports
  53. Uev1A counteracts oncogenic Ras stimuli in both polyploid and diploid cells
    Qi Zhang, Yunfeng Wang, Xueli Fu, Ziguang Wang, Yang Zhang, Lizhong Yan, Yuejia Wang, Muhan Yang, Dan Song, Ruixing Zhang et al. · 2025 · eLife
  54. Uev1A counteracts oncogenic Ras stimuli in both polyploid and diploid cells
    Qi Zhang, Yunfeng Wang, Xueli Fu, Ziguang Wang, Yang Zhang, Lizhong Yan, Yuejia Wang, Muhan Yang, Dan Song, Ruixing Zhang et al. · 2025 · eLife
  55. Exploring LAT-derived miRNAs as regulatory agents of EphrinA3 in glioblastoma multiforme
    Fatemeh Saadatpour, Ehsan Arefian · 2025 · Biochemistry and Biophysics Reports
  56. CRIF counteracts oncogenic Ras and regulates heterochromatin
    Su Jun Lim, Jinghong Li, Willis X. Li · 2025 · Molecular Genetics and Genomics
  57. Co-expression of bovine leukemia virus and bovine foamy virus-derived miRNAs in naturally infected cattle
    Marcos Petersen, Guillermo A. Suarez Archilla, Cecilia Valeria Perez, Diego Daniel Gonzalez, Karina Gabriela Trono, Claudia Mongini, Juan Pablo Jaworski, Hugo Adrián Carignano · 2025 · Microbiology Spectrum
  58. RALGEF inhibitors suppress RAS-driven pancreatic cancer and metastasis
    Howard Donninger, Rachel Ferrill, Becca V. Baby, Katie R Hobbing, William L. Dean, Nagaraju Miriyala, Raphael Jigo, Joseph A. Burlison, John O. Trent, Rob Monsen et al. · 2025 · Journal of Biological Chemistry
  59. Additional file 1 of Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
    Yan, Chi, Richmond, Ann · 2021 · Figshare
  60. Generation of Human Haematopoietic Model Cell Lines Revealed Distinct Replication Stress Tolerance Between Two Oncogenic KRAS Mutations, G12V and A146T
    Mone Okuda, Ryotaro Kawasumi, Kayoko Tanaka, Kouji Hirota · 2026 · Biomolecules
  61. Uev1A counteracts oncogenic Ras stimuli in both polyploid and diploid cells
    Qi Zhang, Yunfeng Wang, Xueli Fu, Ziguang Wang, Yang Zhang, Lizhong Yan, Yuejia Wang, Muhan Yang, Dan Song, Ruixing Zhang et al. · 2026 · eLife
  62. Nutritional and Phytochemical Profile and Potential Anticancer Benefits of Amazonian Exotic Fruits
    Thuane Passos Barbosa Lima, Carolina de Oliveira Ramos Petra de Almeida, Isabela da Mota Leal Lemos, Vanessa Rosse de Souza, Anderson Junger Teodoro · 2025 · Nutrition Reviews
  63. Extracellular Phosphatidic Acid: A Novel Regulator of Lung Cancer Cell Migration – Role of the PI3K/AKT Pathway
    Ana Gómez-Larrauri, Patricia Gangoiti, Laura Camacho, Natalia Presa, C. Martin, Antonio Gómez‐Muñoz · 2026 · Genetics.
  64. Pan-cancer analysis reveals differential PERK expression across tumour types and its potential as a therapeutic target
    Shivam Kumar, Namshik Han, Georgia Tsagkogeorga, M. X. Wan · 2026 · Discover Oncology
  65. Hététogénéité intratumorale et dynamique des populations du carcinome hépatocellulaire : impact de l’intensité de la signalisation Ras/MAPK Erk
    Anthony Lozano · 2021 · theses.fr (ABES)
  66. Study of HOXB8-mediated tumor suppression in a chicken embryo model : towards novel therapeutic targets for ERK-dependent cancers
    Axelle Wilmerding · 2021
  67. Développement d’un assemblage multispécifique de Nanofitines à activité anti-tumorale
    Perrine Jacquot · 2022
  68. Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity
    John N. Colgan, Jack H. Peplinski, Yi-Cheng Wang, Danielle C. Kirkey, Logan K. Wallace, Yuan Feng, Li Fan, Patrick Connerty, Rhonda E. Ries, Adam J. Lamble et al. · 2026 · Blood Advances
  69. COSMIC-Linked Ras Mutations at the Interface Between H-Ras and PI3Kγ RBD Frequently Generate Affinity Increases
    Elizabeth H. Mead, Kaeden C. Batz, Kuo-Hsien Shih, Ian R Fleming, Corey D Tesdahl, Lucas Lizardos, Joy R Armendariz, Jonathan P. Hannan, Ava M. Hickey, Alan Leyk et al. · 2026 · Biochemistry
  70. PI3K/HDAC Dual Inhibitors as Potential Anticancer Therapeutics: An Insight Into Design Strategies and Structure Activity Relationships
    Sandipan Dash, Sheik Shehensha, Arghya Kusum Dhar · 2026 · ChemistrySelect
  71. Benefits and challenges of adding BKM120 to a BI-3406 plus trametinib combination therapy
    Benjamin Schulz, Emily Leitner, Mehrdad Rabierad, Muhammad Imran Khan, Luise Ehlers, Hugo Murua Escobar, Robert Jaster, Brigitte Vollmar, Dietmar Zechner · 2026 · BMC Cancer
  72. Reconstitution of Ras-PI3Kγ membrane communication and feedback using light-induced signaling inputs
    Sophia Doerr, Andres Olavarrieta Colasurdo, Scott D. Hansen · 2026 · Nature Communications
  73. Neuroepithelial cell competition triggers loss of cellular juvenescence.
    孝夫 森宗, 篤史 塚村, 郁実 田埜, Yuya Tanaka, Yasuhiro Mori, Takefumi Yamamoto, 西村, 正樹, 育夫 遠山, Masaki Mori, Faidruz Azura Binti JAM et al. · 2020 · Institutional Repositories DataBase (IRDB)
  74. Regulation of Membrane Association and Downstream Effector Interaction of K-Ras by Its Hypervariable Region
    Anda Trifan, Hossein Omidi-Ardali, Josh V. Vermaas, Till Rudack, Emad Tajkhorshid · 2026 · Membranes
  75. BindingDB Entry 50021163: Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discovery.
    BindingDB · 2025 · UC San Diego